澳股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BIOTRON LIMITED

0.003

0.000

成交量：52.19萬

成交額：1,566.00

市值：398.17萬

市盈率：-1.91

高：0.003

開：0.003

低：0.003

收：0.003

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

BIOTRON LIMITED

交易所：

ASX

成立時間：

1999

員工人數：

3

公司地址：

66 Hunter Street,Level 2,Sydney,New South Wales,Australia

官網：

http://www.biotron.com.au

郵編：

2000

電話：

- -

傳真：

- -

簡介：

Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BIT.AU/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIT.AU\",,,,,undefined,":{"symbol":"BIT.AU","market":"AU","secType":"STK","nameCN":"BIOTRON LIMITED","latestPrice":0.003,"timestamp":1747116720000,"preClose":0.003,"halted":0,"volume":521917,"delay":0,"nameEN":"BIOTRON LIMITED","floatShares":1131782613,"shares":1327245843,"eps":-0.001569,"marketStatus":"未開盤","change":0,"latestTime":"05-13 16:12:00 AEST","open":0.003,"high":0.003,"low":0.003,"amount":1566,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.001569,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1747180800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.003,"openAndCloseTimeList":[[1747094400000,1747116000000]],"volumeRatio":1.4045038458950208,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIT.AU\",,,,,undefined,":{"symbol":"BIT.AU","floatShares":1131782613,"roa":"-51.97%","roe":"-121.67%","lyrEps":-0.003809,"volumeRatio":1.4045038458950208,"shares":1327245843,"dividePrice":0,"high":0.003,"amplitude":0,"preClose":0.003,"low":0.003,"week52Low":0.002,"pbRate":"8.67","psRate":"2.19","week52High":0.058,"institutionHeld":0,"latestPrice":0.003,"eps":-0.001569,"divideRate":0,"volume":521917,"delay":0,"ttmEps":-0.001569,"open":0.003,"prevYearClose":0.016,"prevWeekClose":0.003,"prevMonthClose":0.003,"prevQuarterClose":0.003,"fiveDayClose":0.003,"twentyDayClose":0.003,"sixtyDayClose":0.01},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":7658306,"yearFounded":1999,"employeeNum":3,"address":"66 Hunter Street,Level 2,Sydney,New South Wales,Australia","zipCode":"2000"},"stockCompanyDetail":{"websiteUrl":"http://www.biotron.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.5},{"period":"3month","weight":-0.6667},{"period":"6month","weight":-0.8235},{"period":"1year","weight":-0.9412},{"period":"ytd","weight":-0.8125}],"compareEarnings":[{"period":"1week","weight":-0.003},{"period":"1month","weight":0.0514},{"period":"3month","weight":0.0345},{"period":"6month","weight":0.1389},{"period":"1year","weight":0.1401},{"period":"ytd","weight":0.0986}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.28,"avgChangeRate":-0.06298},{"month":2,"riseRate":0.44,"avgChangeRate":-0.015344},{"month":3,"riseRate":0.24,"avgChangeRate":-0.075071},{"month":4,"riseRate":0.44,"avgChangeRate":0.047428},{"month":5,"riseRate":0.125,"avgChangeRate":-0.140956},{"month":6,"riseRate":0.583333,"avgChangeRate":0.110905},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.016245},{"month":8,"riseRate":0.25,"avgChangeRate":0.059053},{"month":9,"riseRate":0.541667,"avgChangeRate":0.150596},{"month":10,"riseRate":0.333333,"avgChangeRate":0.024497},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.002804},{"month":12,"riseRate":0.458333,"avgChangeRate":0.033506}],"exchange":"ASX","name":"BIOTRON LIMITED","nameEN":"BIOTRON LIMITED"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BIT.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIT.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-03-05","symbol":"BIT.AU","defaultRemindTime":1741129200000,"type":"split","dateTimestamp":1741093200000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIT.AU\",market:\"AU\",,,undefined,":[]}}